MHR
GH icon

Matthew Hamilton Rosenberg’s Guardant Health GH Stock Holding History

Matthew Hamilton Rosenberg’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-15
Closed -$537 – 949
2023
Q2 		$537 Hold
15
– – ﹤0.01% 837
2023
Q1 		$352 Hold
15
– – ﹤0.01% 895
2022
Q4 		$408 Hold
15
– – ﹤0.01% 880
2022
Q3 		$1K Buy
+15
New +$770 ﹤0.01% 817

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Matthew Hamilton Rosenberg's GH Position: Q3 2023 in Review

Matthew Hamilton Rosenberg sold out of Guardant Health (GH) in Q3 2023, closing a stake of 15 shares — an estimated $537 sold.

Matthew Hamilton Rosenberg first reported a position in GH in Q3 2022 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

  • Matthew Hamilton Rosenberg reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
  • Matthew Hamilton Rosenberg sold 15 Guardant Health shares in Q3 2023, an estimated $537.
  • Matthew Hamilton Rosenberg first reported a position in Guardant Health in Q3 2022 and held it in 4 quarters.
  • Matthew Hamilton Rosenberg's Guardant Health position peaked at $1K in Q3 2022.
  • 296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on Matthew Hamilton Rosenberg's 13F filing for Q3 2023, filed 11 Oct 2023.